These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35628815)

  • 21. Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date.
    Kim J; Naclerio R
    Ther Clin Risk Manag; 2020; 16():31-37. PubMed ID: 32158216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics.
    Förster-Ruhrmann U; Stergioudi D; Szczepek AJ; Fluhr JW; Zuberbier T; Olze H; Bergmann KC
    World Allergy Organ J; 2023 Feb; 16(2):100746. PubMed ID: 36852411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis.
    Nakashima D; Nakayama T; Minagawa S; Adachi T; Mitsuyama C; Shida Y; Nakajima T; Haruna SI; Matsuwaki Y
    Allergol Int; 2023 Oct; 72(4):557-563. PubMed ID: 37061391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps.
    Siddiqui S; Bachert C; Chaker AM; Han JK; Hellings PW; Peters AT; Heffler E; Kamat S; Zhang H; Nash S; Khan AH; De Prado Gomez L; Jacob-Nara JA; Rowe PJ; Deniz Y
    ERJ Open Res; 2022 Oct; 8(4):. PubMed ID: 36451848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma.
    Laidlaw TM; Bachert C; Amin N; Desrosiers M; Hellings PW; Mullol J; Maspero JF; Gevaert P; Zhang M; Mao X; Khan AH; Kamat S; Patel N; Graham NMH; Ruddy M; Staudinger H; Mannent LP
    Ann Allergy Asthma Immunol; 2021 May; 126(5):584-592.e1. PubMed ID: 33465455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies.
    Geng B; Bachert C; Busse WW; Gevaert P; Lee SE; Niederman MS; Chen Z; Lu X; Khokhar FA; Kapoor U; Pandit-Abid N; Jacob-Nara JA; Rowe PJ; Deniz Y; Ortiz B
    J Allergy Clin Immunol Pract; 2022 Mar; 10(3):732-741. PubMed ID: 34954123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dupilumab as Add-on Therapy for Chronic Rhinosinusitis With Nasal Polyposis in Aspirin Exacerbated Respiratory Disease.
    Mustafa SS; Vadamalai K; Scott B; Ramsey A
    Am J Rhinol Allergy; 2021 May; 35(3):399-407. PubMed ID: 32967430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis.
    Bachert C; Hellings PW; Mullol J; Hamilos DL; Gevaert P; Naclerio RM; Joish VN; Chao J; Mannent LP; Amin N; Abbe A; Taniou C; Fan C; Pirozzi G; Graham NMH; Mahajan P; Staudinger H; Khan A
    Allergy; 2020 Jan; 75(1):148-157. PubMed ID: 31306495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
    Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A
    Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dupilumab has an additional benefit in treatment of chronic rhinosinusitis with nasal polyps].
    Klimek L; Chaker A; Deitmer T; Plontke SK; Wollenberg B; Bousquet J; Bachert C
    HNO; 2021 Nov; 69(11):868-877. PubMed ID: 33738558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biologics for chronic rhinosinusitis.
    Chong LY; Piromchai P; Sharp S; Snidvongs K; Webster KE; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013513. PubMed ID: 33710614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study
    D'Amato M; Menzella F; Altieri E; Bargagli E; Bracciale P; Brussino L; Caiaffa MF; Canonica GW; Caruso C; Centanni S; De Michele F; Di Marco F; Pastorello EA; Pelaia G; Rogliani P; Romagnoli M; Schino P; Senna G; Vultaggio A; Ori A; Simoni L; Boarino S; Vitiello G; Aliani M; Del Giacco S
    Front Allergy; 2022; 3():881218. PubMed ID: 35769575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid effect of benralizumab for severe asthma with chronic rhinosinusitis with nasal polyps.
    Matsuno O; Minamoto S
    Pulm Pharmacol Ther; 2020 Oct; 64():101965. PubMed ID: 33039667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNP.
    Minagawa S; Araya J; Watanabe N; Fujimoto S; Watanabe J; Hara H; Numata T; Kuwano K; Matsuwaki Y
    BMC Pulm Med; 2022 Jun; 22(1):258. PubMed ID: 35764984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study.
    Nolasco S; Crimi C; Pelaia C; Benfante A; Caiaffa MF; Calabrese C; Carpagnano GE; Ciotta D; D'Amato M; Macchia L; Pelaia G; Pellegrino S; Scichilone N; Scioscia G; Spadaro G; Campisi R; Valenti G; Vatrella A; Crimi N
    J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4371-4380.e4. PubMed ID: 34419679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps.
    Kilty SJ; Lasso A
    J Otolaryngol Head Neck Surg; 2022 Apr; 51(1):17. PubMed ID: 35468866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma.
    Iino Y; Sekine Y; Yoshida S; Kikuchi S
    Auris Nasus Larynx; 2021 Jun; 48(3):353-360. PubMed ID: 32943257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dupilumab: Clinical Efficacy of Blocking IL-4/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps.
    Kariyawasam HH; James LK; Gane SB
    Drug Des Devel Ther; 2020; 14():1757-1769. PubMed ID: 32440101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis.
    Heffler E; Saccheri F; Bartezaghi M; Canonica GW
    Clin Transl Allergy; 2020; 10():25. PubMed ID: 32607141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-Utility Analysis of Dupilumab for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Italy.
    De Corso E; Furneri G; Salsi D; Fanelli F; Ronci G; Sala G; Bitonti R; Cuda D
    J Pers Med; 2022 Jun; 12(6):. PubMed ID: 35743736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.